Comparison of main trials of recombinant human activated protein C in sepsis-are we encouraging more bleeding in neonates?

Hsin Shieh, Huei; Roseli Barreira, Eliane; Freitas Góes, Patricia; Bousso, Albert; Ventura Brazilian, Gabriel Alberto; Melo, Ana Maria; Ibidi, Silvia Maria

Hsin Shieh, Huei; Roseli Barreira, Eliane; Freitas Góes, Patricia; Bousso, Albert; Ventura Brazilian, Gabriel Alberto; Melo, Ana Maria; Ibidi, Silvia Maria.

Pediatr Crit Care Med ; 11(6): 767-8; author reply 768-9, 2010 Nov.

Article in En | MEDLINE | ID: mdl-21057275

Subject(s)

Antithrombin III/metabolism; Protein C/metabolism; Sepsis/physiopathology; Antithrombin III/analysis; Blood Coagulation/physiology; Clinical Trials as Topic; Enterocolitis, Necrotizing/epidemiology; Enterocolitis, Necrotizing/etiology; Enterocolitis, Necrotizing/prevention & control; Humans; Infant, Newborn; Intracranial Hemorrhages/epidemiology; Intracranial Hemorrhages/etiology; Intracranial Hemorrhages/prevention & control; Protein C/analysis; Protein S/analysis; Protein S/metabolism; Risk Assessment; Sepsis/complications; Severity of Illness Index; Thromboembolism/prevention & control

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein C / Antithrombin III / Sepsis Type of study: Etiology_studies / Risk_factors_studies Limits: Humans / Newborn Language: En Journal: Pediatr Crit Care Med Journal subject: PEDIATRIA / TERAPIA INTENSIVA Year: 2010 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google